Browsing Tag
Vascepa
4 posts
AHA 2025: New REDUCE-IT results reveal Vascepa lowers heart attack and stroke risk even when LDL-C is optimal
Find out how AHA 2025 REDUCE-IT results show Vascepa reduces heart attack and stroke risk even when LDL-C is optimal — reshaping cardiovascular prevention.
Strides Pharma, Amneal Pharmaceuticals partner to launch Icosapent ethyl capsules
Strides Pharma Science Limited (“Strides”) has joined forces with Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) to introduce Icosapent…
Strides Pharma receives FDA approval for Icosapent Ethyl Capsules
Strides Pharma Science Limited (Strides) has achieved a significant milestone by announcing the United States Food & Drug…
Amarin bags Vascepa FDA approval for reducing cardiovascular risk
Vascepa FDA approval : New Jersey-based Amarin has secured approval from the US Food and Drug Administration (FDA)…